| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |